Market evolution: X-ray apparatus (CN 902214) — 2015–2025

Introduction

This report examines the EU's external trade in medical, surgical and veterinary X-ray apparatus (excluding dental and CT equipment) over the period 2015–2025, based on complete annual trade data. The EU has consistently maintained a strong trade surplus in this sector, with exports far exceeding imports. However, the decade reveals a notable structural shift: while the EU's export dominance persisted, import growth outpaced exports significantly, driven by rising import unit values and new sourcing patterns. The analysis below identifies three principal dynamics shaping this market: the resilience and evolution of EU exports, the emergence of new trade corridors and partners, and the growing exposure to import-side volatility and price risks.

1. Sustained Export Dominance with Moderate Growth

The EU remained a major net exporter of medical X-ray apparatus throughout the period, though the pace of export growth was moderate compared to the import surge. The trade balance grew from €1.72 billion in 2015 to €2.04 billion in 2025 (+18.7%), reflecting the EU's structural advantage in high-value medical equipment manufacturing.

1.1 Export volumes grew faster than export values, indicating price compression

EU exports rose from €2.05 billion to €2.62 billion (+27.7%) over the decade. However, export volume in tonnes grew even faster (+37.3%), which means the average export price per tonne actually declined by 7.0% — from €150,890 to €140,332 per tonne. A similar pattern appears in the supplementary unit data: the number of items exported grew by 38.0% (from 46,236 to 63,816 units), while the per-unit price fell by 7.5% (from €44,336 to €41,019). This suggests either increasing competition in export markets, a shift toward mid-range product mix, or intensifying price pressure from Asian manufacturers.

1.2 Germany and the Netherlands dominated EU exports, but with diverging trajectories

Among EU member states by export value, Germany remained the largest exporter (€1.04 billion in 2025, +5.0%), but the Netherlands overtook it in relative growth, expanding from €675 million to €1.15 billion (+70.4%). Italy also emerged as a fast-growing exporter (+108.2%, reaching €116 million), while France and Spain saw declines of 18.8% and 31.0% respectively.

1.3 EU production expanded significantly, reinforcing export capacity

According to production volume data, EU production of medical X-ray apparatus grew from 95,088 to 180,000 items (+89.3%) and production value rose from €2.96 billion to €5.03 billion (+70.0%). This expansion underpinned the EU's continued ability to supply both domestic demand and export markets, even as the composition of trade flows shifted.

2. New Trade Corridors and Shifting Partner Dynamics

The geography of EU trade in medical X-ray apparatus evolved considerably over the decade. While traditional partners like the United States remained dominant, several new or previously minor partners gained importance — both as export destinations and as import sources.

2.1 The United States remained the EU's top export and import partner

The top partners by value data confirms the centrality of the US market. EU exports to the US grew from €754 million to €965 million (+28.0%), while imports from the US rose from €188 million to €211 million (+11.9%). The transatlantic corridor thus remained the backbone of EU trade in this sector, with the EU maintaining a large bilateral surplus.

2.2 India and Türkiye emerged as fast-growing export markets

Several non-traditional partners saw rapid growth in EU exports:

India's import needs in medical imaging — driven by hospital expansion and public health programmes — made it one of the fastest-growing markets for EU exporters. However, exports to China declined by 29.3% (from €257 million to €182 million), likely reflecting China's growing domestic production capacity and import substitution policies.

2.3 The United Kingdom became a major import source, likely reflecting post-Brexit trade restructuring

One of the most dramatic shifts occurred in EU imports from the United Kingdom: rising from €19.5 million to €151.4 million (+677.2%). This likely reflects the reclassification of UK-origin goods as non-EU imports after Brexit, combined with continued manufacturing activity in the UK by multinationals serving EU markets.

2.4 Mexico became a significant import source from a negligible base

EU imports from Mexico surged from just €148,000 in 2015 to €36.8 million in 2025 (+24,736%). While starting from a very low base, this explosive growth suggests the emergence of Mexico as a manufacturing platform for medical device companies serving the EU market — possibly driven by nearshoring strategies or the expansion of multinational production footprints.

2.5 Import concentration fell, indicating diversification of sourcing

The Herfindahl-Hirschman Index (HHI) for imports by value declined by 33.5% (from 3,550 to 2,360), moving from a moderately concentrated market toward a less concentrated one. This diversification reduces single-source dependency but also introduces greater complexity in supply chain management. Export concentration, already lower, declined modestly (−7.6%).

3. Rising Import Costs, Price Shocks, and Strategic Implications

While the EU's trade surplus remained robust, the import side of the market exhibited concerning dynamics: volumes fell while values surged, indicating sharply rising unit costs. Combined with detected price shocks and volatility in certain partner relationships, these trends raise questions about the EU's evolving vulnerability in medical imaging supply chains.

3.1 Import prices more than doubled, even as import volumes declined

This is perhaps the most striking trend in the data. EU imports fell by 11.6% in tonnage (from 6,562 to 5,798 tonnes) and by 43.8% in item count (from 59,685 to 33,562 units), yet import value grew by 74.4% (from €332 million to €580 million). The consequence: import unit prices nearly doubled per tonne (+97.4%, from €50,638 to €99,963) and more than tripled per item (+210.2%, from €5,567 to €17,270). This suggests the EU is increasingly importing higher-value, more specialized apparatus rather than commodity-grade equipment.

3.2 Price shocks were detected in key bilateral relationships

The supply shock analysis identified three significant events:

The UK import price shock in 2018 (with an abnormality score of 88.9 and a 794% price shift) is by far the most extreme event detected. This likely coincides with the period of Brexit transition uncertainty and the early reconfiguration of supply chains. The Russian export price decline in 2022 reflects the impact of EU sanctions following the invasion of Ukraine, which disrupted established trade flows.

3.3 The EU's net export position strengthened, but export propensity reveals growing trade dependence

The net import reliance metric remained deeply negative (from −53.7% to −232.2%), confirming the EU's status as a major net exporter. However, two other indicators paint a more nuanced picture:

• Trade intensity (exports + imports as a share of production) rose from 59.1% to 94.5% (+59.9%).
• Export propensity (exports as a share of production) rose from 52.1% to 93.2% (+79.0%).

This means that the EU medical X-ray industry is now substantially more dependent on export markets than it was a decade ago. While this reflects commercial success, it also implies greater exposure to geopolitical disruptions, trade policy changes, and demand fluctuations in partner countries.

3.4 Specialisation was concentrated in a handful of member states

The revealed comparative advantage data for 2025 shows that export specialisation in medical X-ray apparatus is highly uneven across the EU:

The Netherlands and France display the strongest comparative advantages, while most other member states are net importers or have negligible specialisation. This concentration means that the EU's competitive position in this sector depends heavily on industrial capabilities in just a few countries.

Conclusion

Over 2015–2025, the EU maintained its position as a major net exporter of medical X-ray apparatus, with export values growing by 27.7% and the trade surplus widening to over €2 billion. However, the period was marked by several structural shifts that warrant attention. Import values grew much faster than export values (+74.4% vs. +27.7%), driven by a near-doubling of import unit prices rather than volume growth — suggesting the EU is increasingly sourcing higher-specification or niche equipment from third countries. The import landscape diversified significantly (HHI fell by 33.5%), with new partners like Mexico and a post-Brexit United Kingdom gaining importance. On the export side, the EU's industry became substantially more trade-dependent, with export propensity rising from 52% to 93% of production. While this reflects global competitiveness, it also heightens sensitivity to external demand shocks and trade policy disruptions, as evidenced by the sanctions-driven perturbation in Russian trade and the price volatility detected in UK import flows. Looking forward, the EU's strategic autonomy in this critical medical technology sector will depend on sustaining innovation leadership while managing the growing complexity and cost pressures of its import supply chains.